Evotec & Scynexis to lead the workshops for Superbugs & Superdrugs 2020
SMi Reports: Interactive workshop overview for SMi's 22nd Annual Superbugs & Superdrugs Conference, London in March 2020
By: SMi Group
The issue of developing and commercialising novel antibiotics whilst simultaneously making a return for investors continues to be a big problem. This year's Superbugs & Superdrugs event aims to address these issues via a series of informative presentations by an international gathering of senior industry experts, scientific pioneers, and academics.
For interested individuals, the final early bird saving of £100 made by 31st January 2020, is available at www.superbugssuperdrugs.com/
The upcoming Superbugs & Superdrugs 2020 will host 2 post-conference workshops taking place on 1st April, including:
Workshop A: 'Development of Non-Traditional Agents and Alternatives to Antibiotics' led by Peter Warn, Senior Vice President Anti-infective Discovery, Evotec (UK) Ltd and Antonio Felici, VP, Anti-Infectives, Evotec
Workshop B: 'Anti-microbial Resistance and Pathogenic Fungi' led by Stephen Barat, VP, Preclinical Research and Early Development, Scynexis
These interactive workshops will discuss a variety of topics such as: the in vitro and in vivo developments of non-traditional antibacterial agents, the emergence of multi-drug resistance strains pose substantial health threats and many more.
The full agenda and speaker line-up and workshop information is available online at www.superbugssuperdrugs.com/
For sponsorship enquiries contact Alia Malick on +44 (0)20 7827 6164 or amalick@smi-
For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or email@example.com
Superbugs & Superdrugs 2020
Conference: 30th – 31st March 2020
Workshops: 1st April 2020
Holiday Inn Kensington Forum, London, UK